1 |
Abraham, R. T. 2001. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196.
DOI
|
2 |
Adams, R. L. and Lindsay, J. G. 1967. Hydroxyurea: reversal of inhibition and use as a cell synchronizing agent. J. Biol. Chem. 242, 1314-1317.
|
3 |
Amaravadi, R. K. and Thompson, C. B. 2007. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13, 7271-7279.
DOI
|
4 |
Andreassen, P. R., Lohez, O. D., Lacroix, F. B. and Margolis, R. L. 2001. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 12, 1315-1328.
DOI
|
5 |
Aylon, Y., Michael, D., Shmueli, A., Yabuta, N., Nojima, H. and Oren, M. 2006. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20, 2687-2700.
DOI
|
6 |
Blagosklommy, M. V., Schulte, T., Nguyen, P., Trepel, J. and Neckers, L. M. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56, 1851-1854.
|
7 |
Brito, D. A. and Rieder, C. L. 2006. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol. 16, 1194-1200.
DOI
|
8 |
Burke, D. J. and Stukenberg, P. T. 2008. Linking kinetochoremicrotubule binding to the spindle checkpoint. Developmental Cell 14, 474-479.
DOI
|
9 |
Castedo, M., Coquelle, A., Vivet, S., Vitale, I., Kauffmann, A., Dessen, P., Pequignot, M. O., Casares, N., Valent, A., Mouhamad, S., Schmitt, E., Modjtahedi, N., Vainchenker, W., Zitvogel, L., Lazar, V., Garrido, C. and Kroemer, G. 2006. Apoptosis regulation in tetraploid cancer cells. EMBO J. 25, 2584-2595.
DOI
|
10 |
Cavenee, W. K. and White, R. L. 1995. The genetic basis of cancer. Sci. Am. 272, 72-79.
|
11 |
Chipuk, J. E. and Green, D. R. 2008. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18, 157-164.
DOI
|
12 |
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J. and Green, D. R. 2010. The BCL-2 family reunion. Mol. Cell 37, 299-310.
DOI
|
13 |
Chu, R., Terrano, D. T. and Chambers, T. C. 2010. Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration. Biochem. Pharmacol. 83, 199-206.
|
14 |
Contreras, A., Hale, T. K., Stenoien, D. L., Rosen, J. M., Mancini, M. A. and Herrera, R. E. 2003. The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation. Mol. Cell. Biol. 23, 8626-8636.
DOI
|
15 |
Czabotar, P. E., Colman, P. M. and Huang, D. C. 2009. Bax activation by Bim? Cell Death Differ. 16, 1187-1191.
DOI
|
16 |
Donzelli, M. and Draetta, G. F. 2003. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 4, 671-677.
DOI
|
17 |
De Chiara, G., Marcocci, M. E., Torcia, M., Lucibello, M., Rosini, P., Bonini, P., Higashimoto, Y., Damonte, G., Armirotti, A., Amodei, S., Palamara, A. T., Russo, T., Garaci, E. and Cozzolino, F. 2006. Bcl-2 phosphorylation by p38 MAPK: identification of target sites and biologic consequences. J. Biol. Chem. 281, 21353-21361.
DOI
|
18 |
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gelinas, C., Fan, Y., Nelson, D. A. and Jin, S. 2006. White E. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64.
DOI
|
19 |
Desagher, S. and Martinou, J. C. 2000. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377.
DOI
|
20 |
Etienne-Manneville, S. 2010. From signaling pathways to microtubule dynamics: the key players. Curr. Opin. Cell Biol. 22, 104-111.
DOI
|
21 |
Fesquet, D., Labbe, J. C., Derancourt, J., Capony, J. P., Galas, S., Girard, F., Lorca, T., Shuttleworth, J., Doree, M. and Cavadore, J. C. 1993. The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues. EMBO J. 12, 3111-3121.
|
22 |
Furukawa, Y., Iwase, S., Kikuchi, J., Terui, Y., Nakamura, M., Yamada, H., Kano, Y. and Matsuda, M. 2000. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation. J. Biol. Chem. 275, 21661-21667.
DOI
|
23 |
Gabrielli, B., Brooks, K. and Pavey, S. 2012. Defective cell cycle checkpoints as targets for anti-cancer therapies. Front. Pharmacol. 3, 9.
|
24 |
Han, C. R., Jun, D. Y., Kim, Y. H., Lee, J. Y. and Kim, Y. H. 2013. Prometaphase arrest-dependent phosphorylation of Bcl-2 family proteins and activation of mitochondrial apoptotic pathway are associated with 17α-estradiol-induced apoptosis in human Jurkat T cells. Biochim. Biophys. Acta 1833, 2220-2232.
DOI
|
25 |
Gadde, S. and Heald, R. 2004. Mechanisms and molecules of the mitotic spindle. Curr. Biol. 14, R797-805.
DOI
|
26 |
Goshima, G. and Scholey, J. M. 2010. Control of mitotic spindle length. Annu. Rev. Cell Dev. Biol. 26, 21-57.
DOI
|
27 |
Hainaut, P. and Hollstein, M. 2000. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77, 81-137.
|
28 |
Han, C. R., Jun, D. Y., Lee, J. Y. and Kim, Y. H. 2014. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells. Apoptosis 19, 224-240.
DOI
|
29 |
Hanahan, D. and Weinberg, R. A. 2000. The hallmarks of cancer. Cell 100, 57-70.
DOI
|
30 |
Hannun, Y. A. 1997. Apoptosis and dilemma of cancer chemotheraphy. Blood 89, 1845-1853.
|
31 |
Harley, M. E., Allan, L. A., Sanderson, H. S. and Clarke, P. R. 2010. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J. 29, 2407-2420.
DOI
|
32 |
Hartwell, L. H. and Weinert, T. A. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246, 629-634.
DOI
|
33 |
Hochegger, H., Takeda, S. and Hunt, T. 2008. Cyclin-dependent kinases and cell-cycle transitions: does one fit all? Nat. Rev. Mol. Cell Biol. 9, 910-916.
|
34 |
Ibrado, A. M., Kim, C. N. and Bhalla, K. 1998. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome c and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells. Leukemia 12, 1930-1936.
DOI
|
35 |
Holloway, S. L., Glotzer, M., King, R. W. and Murray, A. W. 1993. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell 73, 1393-1402.
DOI
|
36 |
Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorlie, T., Hovig, E., Smith-Sorensen, B., Montesano, R. and Harris, C. C. 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22, 3551-3555.
|
37 |
Huang, J. and Klionsky, D. J. 2007. Autophagy and human disease. Cell Cycle 6, 1837-1849.
DOI
|
38 |
Jordan, M. A. and Wilson, L. 2004. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265.
DOI
|
39 |
Kastan, M. B. and Bartek, J. 2004. Cell-cycle checkpoints and cancer. Nature 432, 316-323.
DOI
|
40 |
Kaufman, S. H. and Earnshaw, W. C. 2000. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.
DOI
|
41 |
Kim, Y. H., Proust, J. J., Buchholz, M. J., Chrest, F. J. and Nordin, A. A. 1992. Expression of the murine homologue of the cell cycle control protein p34cdc2 in T lymphocytes. J. Immunol. 149, 17-23.
|
42 |
Krokan, H., Wist, E. and Krokan, R. H. 1981. Aphidicolin inhibits DNA synthesis by DNA polymerase alpha and isolated nuclei by a similar mechanism. Nucleic Acids Res. 9, 4709-4719.
DOI
|
43 |
Kuntz, K. and O'Connell, M. J. 2009. The G2 DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer? Cancer Biol. Ther. 8, 1433-1439.
|
44 |
Mansilla, S., Llovera, L. and Portugal, J. 2012. Chemotherapeutic targeting of cell death pathways. Anticancer Agents Med. Chem. 12, 226-238.
DOI
|
45 |
Lapenna, S. and Giordano, A. 2009. Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8, 547-566.
DOI
|
46 |
Lee, S. T., Lee, J. Y., Han, C. R., Kim, Y. H., Jun, D. Y., Taub, D. and Kim, Y. H. 2015. Dependency of 2-methoxyestradiol-induced mitochondrial apoptosis on mitotic spindle network impairment and prometaphase arrest in human Jurkat T cells. Biochem. Pharmacol. 94, 257-269.
DOI
|
47 |
Li, Y. M. and Broome, J. 1999. Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells, Cancer Res. 59, 776-780.
|
48 |
Margolis, R. L. 2005. Tetraploidy and tumor development. Cancer Cell 8, 353-354.
DOI
|
49 |
Mathias, S. and Holger, B. 2007. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Drug Resist. Update 10, 162-181.
DOI
|
50 |
Maton, G., Thibier, C., Castro, A., Lorca, T., Prigent, C. and Jessus, C. 2003. Cdc2-cyclin B triggers H3 kinase activation of Aurora-A in Xenopus oocytes. J. Biol. Chem. 278, 21439-21449.
DOI
|
51 |
McGrogan, B. T., Gilmartin, B., Carney, D. N. and McCann, A. 2008. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta. 1785, 96-132.
|
52 |
Mollinedo, F. and Gajate, C. 2003. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8, 413-450.
DOI
|
53 |
Morgan, G., Wardy, R. and Bartonz, M. 2004. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin. Oncol. 16, 549-560.
DOI
|
54 |
Ogden, A., Rida, P. C., Knudsen, B. S., Kucuk, O. and Aneja, R. 2015. Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse. Cancer Lett. 367, 89-92.
DOI
|
55 |
Murray, A. 1994. Cell cycle checkpoints. Curr. Opin. Cell Biol. 6, 872-876.
DOI
|
56 |
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. and Yuan, J. 2000. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
DOI
|
57 |
Nitta, M., Tsuiki, H., Arima, Y., Harada, K., Nishizaki, T., Sasaki, K., Mimori, T., Ushio, Y. and Saya, H. 2002. Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability. Genes Cells 7, 151-162.
DOI
|
58 |
Ohi, R. and Gould, K. L. 1999. Regulating the onset of mitosis. Curr. Opin. Cell Biol. 11, 267-273.
DOI
|
59 |
Pathan, N., Aime-Sempe, C., Kitada, S., Haldar, S. and Reed, J. C. 2001. Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. Neoplasia 3, 70-79.
DOI
|
60 |
Rathinasamy, K. and Panda, D. 2006. Suppression of microtubule dynamics by benomyl decreases tension across kinetochore pairs and induces apoptosis in cancer cells. FEBS J. 273, 4114-4128.
DOI
|
61 |
Ricci, M. S. and Zong, W. X. 2006. Chemotherapeutic approaches for targeting cell death pathways. Oncologist 11, 342-357.
DOI
|
62 |
Robles, A., Linke, S. P. and Harris, C. C. 2002. The p53 network in lung carcinogenesis. Oncogene 21, 6898-6907.
DOI
|
63 |
Sherr, C. J. 1996. Cancer cell cycles. Science 274, 1672-1677.
DOI
|
64 |
Takahashi, Y., Ogra, Y. and Suzuki, K. T. 2004. Synchronized generation of reactive oxygen species with the cell cycle. Life Sci. 75, 301-311.
DOI
|
65 |
Singh, P., Rathinasamy, K., Mohan, R. and Panda, D. 2008. Microtubule assembly dynamic: An attractive target for anticancer drugs. IUBMB Life 60, 368-375.
DOI
|
66 |
Srivastava, R. K., Srivastava, A. R., Korsmeyer, S. J., Nesterova, M., Cho-Chung, Y. S. and Longo, D. L. 1998. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell Biol. 18, 3509-3517.
DOI
|
67 |
Steigemann, P., Wurzenberger, C., Schmitz, M. H., Held, M., Guizetti, J., Maar, S. and Gerlich, D. W. 2009. Aurora Bmediated abscission checkpoint protects against tetraploidization. Cell 136, 473-484.
DOI
|
68 |
Terrano, D. T., Upreti, M. and Chambers, T. C. 2010. Cyclin-dependent kinase 1-mediated Bcl-xL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol. Cell Biol. 30, 640-656.
DOI
|
69 |
Tighe, A., Johnson, V. L. and Taylor, S. S. 2004. Truncating APC mutations have dominant effects on proliferation, spindle checkpoint control, survival and chromosome stability. J. Cell Sci. 117, 6339-6353.
DOI
|
70 |
Uetake, Y. and Sluder, G. 2004. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a tetraploidy checkpoint. J Cell Biol 165, 609-615.
DOI
|
71 |
van der Vaart, B., Akhmanova, A. and Straube, A. 2009. Regulation of microtubule dynamic instability. Biochem. Soc. Trans. 37, 1007-10013.
DOI
|
72 |
Vogel, C., Kienitz, A., Hofmann, I., Muller, R. and Bastians, H. 2004. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy. Oncogene 23, 6845-6853.
DOI
|
73 |
Wittmann, T., Hyman, A. and Desai, A. 2001. The spindle: a dynamic assembly of microtubules and motors. Nat. Cell Biol. 3, E28-34.
DOI
|
74 |
Waldman, T., Lengauer, C., Kinzler, K. W. and Vogelstein, B. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
DOI
|
75 |
Wallach, D., Boldin, M., Varfolomeev, E., Beyaert, R., Vandenabeele, P. and Fiers, W. 1997. Cell death induction by receptors of the THF family: towards a molecular understanding. FEBS Lett. 410, 96-106.
DOI
|
76 |
Watanabe, N., Broome, M. and Hunter, T. 1995. Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J. 14, 1878-1891.
|
77 |
Wong, C. and Stearns, T. 2005. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biol. 6, 6.
DOI
|
78 |
Woods, C. M., Zhu, J., McQuenet, P. A., Bollag, D. and Lazarides, E. 1995. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1, 506-526.
|
79 |
World Health Organization. World cancer report, 2014. In: WHO, eds. WHO Report. Geneva: WHO; 2014.
|
80 |
Yamamoto, K., Ichijo, H. and Korsmeyer, S. J. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol. Cell Biol. 19, 8469-8478.
DOI
|